细胞周期蛋白:将细胞周期与肿瘤联系起来。

IF 2 4区 医学 Q3 ONCOLOGY
Oncology Research Pub Date : 2025-05-29 eCollection Date: 2025-01-01 DOI:10.32604/or.2025.058760
Jie Zhong, Jue Liu, Xing Tang, Wenchao Zhou, Guangming Song, Yuhuan Zeng, Xiaodi Zhang, Jianbin Zhou, L U Cao, Qunfeng Zhang, Yukun Li
{"title":"细胞周期蛋白:将细胞周期与肿瘤联系起来。","authors":"Jie Zhong, Jue Liu, Xing Tang, Wenchao Zhou, Guangming Song, Yuhuan Zeng, Xiaodi Zhang, Jianbin Zhou, L U Cao, Qunfeng Zhang, Yukun Li","doi":"10.32604/or.2025.058760","DOIUrl":null,"url":null,"abstract":"<p><p>The cell cycle is a tightly coupled series of events that enable cells to grow and proliferate. Cyclin-dependent kinases (CDKs) play crucial roles in the cell cycle by enabling cells to transition between different phases when they are activated. Cell cycle proteins enhance the activity of CDKs, while natural CDK inhibitors (CDKIs) suppress them. The cell cycle continues in cycles under normal conditions, but when conditions change, cells halt or terminate the cell cycle. Tumors are tissues that grow out of control, and the mechanisms of various types of tumors are different; however, almost all tumor cells share several common characteristics, including proliferation, prevention of apoptosis and genomic instability. Cellular division is essential in the progression of cancer. A key characteristic of cancer is the uncontrolled growth of tumor cells, which is due to the erratic behavior of several proteins during the cell cycle. Therefore, cell cycle regulators are considered attractive targets for the treatment of cancer. The present analysis highlights proteins that play a direct role in controlling the tumor cell cycle, such as CDKs, and provides a brief overview of checkpoint kinases. The present review also discusses how cell cycle proteins contribute to cancer and describes some of the antitumor drugs that are being researched.</p>","PeriodicalId":19537,"journal":{"name":"Oncology Research","volume":"33 6","pages":"1335-1346"},"PeriodicalIF":2.0000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12144634/pdf/","citationCount":"0","resultStr":"{\"title\":\"Cell cycle proteins: Linking the cell cycle to tumors.\",\"authors\":\"Jie Zhong, Jue Liu, Xing Tang, Wenchao Zhou, Guangming Song, Yuhuan Zeng, Xiaodi Zhang, Jianbin Zhou, L U Cao, Qunfeng Zhang, Yukun Li\",\"doi\":\"10.32604/or.2025.058760\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The cell cycle is a tightly coupled series of events that enable cells to grow and proliferate. Cyclin-dependent kinases (CDKs) play crucial roles in the cell cycle by enabling cells to transition between different phases when they are activated. Cell cycle proteins enhance the activity of CDKs, while natural CDK inhibitors (CDKIs) suppress them. The cell cycle continues in cycles under normal conditions, but when conditions change, cells halt or terminate the cell cycle. Tumors are tissues that grow out of control, and the mechanisms of various types of tumors are different; however, almost all tumor cells share several common characteristics, including proliferation, prevention of apoptosis and genomic instability. Cellular division is essential in the progression of cancer. A key characteristic of cancer is the uncontrolled growth of tumor cells, which is due to the erratic behavior of several proteins during the cell cycle. Therefore, cell cycle regulators are considered attractive targets for the treatment of cancer. The present analysis highlights proteins that play a direct role in controlling the tumor cell cycle, such as CDKs, and provides a brief overview of checkpoint kinases. The present review also discusses how cell cycle proteins contribute to cancer and describes some of the antitumor drugs that are being researched.</p>\",\"PeriodicalId\":19537,\"journal\":{\"name\":\"Oncology Research\",\"volume\":\"33 6\",\"pages\":\"1335-1346\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-05-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12144634/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.32604/or.2025.058760\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.32604/or.2025.058760","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

细胞周期是一系列紧密耦合的事件,使细胞能够生长和增殖。细胞周期蛋白依赖性激酶(CDKs)在细胞周期中起着至关重要的作用,当它们被激活时,它使细胞能够在不同的阶段之间转换。细胞周期蛋白增强CDK的活性,而天然CDK抑制剂(CDKIs)抑制它们。细胞周期在正常情况下循环进行,但当条件发生变化时,细胞停止或终止细胞周期。肿瘤是生长失控的组织,不同类型的肿瘤发生机制不同;然而,几乎所有的肿瘤细胞都有几个共同的特征,包括增殖、防止细胞凋亡和基因组不稳定性。细胞分裂在癌症的发展过程中是必不可少的。癌症的一个关键特征是肿瘤细胞不受控制的生长,这是由于细胞周期中几种蛋白质的不稳定行为。因此,细胞周期调节因子被认为是治疗癌症的有吸引力的靶点。目前的分析强调了在控制肿瘤细胞周期中起直接作用的蛋白质,如CDKs,并提供了检查点激酶的简要概述。本文还讨论了细胞周期蛋白对癌症的影响,并介绍了一些正在研究的抗肿瘤药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cell cycle proteins: Linking the cell cycle to tumors.

The cell cycle is a tightly coupled series of events that enable cells to grow and proliferate. Cyclin-dependent kinases (CDKs) play crucial roles in the cell cycle by enabling cells to transition between different phases when they are activated. Cell cycle proteins enhance the activity of CDKs, while natural CDK inhibitors (CDKIs) suppress them. The cell cycle continues in cycles under normal conditions, but when conditions change, cells halt or terminate the cell cycle. Tumors are tissues that grow out of control, and the mechanisms of various types of tumors are different; however, almost all tumor cells share several common characteristics, including proliferation, prevention of apoptosis and genomic instability. Cellular division is essential in the progression of cancer. A key characteristic of cancer is the uncontrolled growth of tumor cells, which is due to the erratic behavior of several proteins during the cell cycle. Therefore, cell cycle regulators are considered attractive targets for the treatment of cancer. The present analysis highlights proteins that play a direct role in controlling the tumor cell cycle, such as CDKs, and provides a brief overview of checkpoint kinases. The present review also discusses how cell cycle proteins contribute to cancer and describes some of the antitumor drugs that are being researched.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Oncology Research
Oncology Research 医学-肿瘤学
CiteScore
4.40
自引率
0.00%
发文量
56
审稿时长
3 months
期刊介绍: Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信